Skip to main content

Table 4 Prevalent and incident use of psychotropic medicines during the perinatal period

From: Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance

N = 343,299

Prevalent use in pregnancy

Prevalent use in pregnancy; > 1 Rx*

Incident use in pregnancy

Incident use in pregnancy > 1 Rx*

Incident use postpartum

Antidepressants

15253 (4.4)

11588 (3.4)

7,022 (2.1)

5353 (1.6)

15652 (4.6)

 SSRI

10998 (3.2)

8300 (2.4)

6,416 (1.9)

5079 (1.5)

14625 (4.3)

Anxiolytics

4574 (1.3)

2992 (0.9)

9961 (2.9)

7100 (2.1)

7583 (2.2)

 Benzo**

4271 (1.2)

2742 (0.8)

9,215 (2.7)

6657 (1.9)

7319 (2.1)

Antipsychotic

559 (0.2)

365 (0.1)

1814 (0.5)

854 (0.3)

773 (0.2)

 Typical antipsychotic

27 (0.01)

14 (0.00)

1546 (0.5)

698 (0.2)

326 (0.1)

 Atypical antipsychotic

480 (0.1)

307 (0.09)

262 (0.1)

158 (0.05)

447 (0.1)

ADHD

1741 (0.5)

886 (0.3)

321 (0.1)

135 (0.04)

604 (0.2)

  1. *Removes women who only filled one prescription in the first trimester.
  2. **benzodiazepine or benzodiazepine like product.